Methyl-CpG-binding protein 2 mediates overlapping mechanisms across brain disorders

Abstract MECP2 and its product, Methyl-CpG binding protein 2 (MeCP2), are mostly known for their association to Rett Syndrome (RTT), a rare neurodevelopmental disorder. Additional evidence suggests that MECP2 may underlie other neuropsychiatric and neurological conditions, and perhaps modulate commo...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Snow Bach, Niamh M. Ryan, Paolo Guasoni, Aiden P. Corvin, Rania A. El-Nemr, Danyal Khan, Albert Sanfeliu, Daniela Tropea
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2020
Materias:
R
Q
Acceso en línea:https://doaj.org/article/892f713a12fe47c58b87bf791fac1f20
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:892f713a12fe47c58b87bf791fac1f20
record_format dspace
spelling oai:doaj.org-article:892f713a12fe47c58b87bf791fac1f202021-12-02T13:33:59ZMethyl-CpG-binding protein 2 mediates overlapping mechanisms across brain disorders10.1038/s41598-020-79268-02045-2322https://doaj.org/article/892f713a12fe47c58b87bf791fac1f202020-12-01T00:00:00Zhttps://doi.org/10.1038/s41598-020-79268-0https://doaj.org/toc/2045-2322Abstract MECP2 and its product, Methyl-CpG binding protein 2 (MeCP2), are mostly known for their association to Rett Syndrome (RTT), a rare neurodevelopmental disorder. Additional evidence suggests that MECP2 may underlie other neuropsychiatric and neurological conditions, and perhaps modulate common presentations and pathophysiology across disorders. To clarify the mechanisms of these interactions, we develop a method that uses the binding properties of MeCP2 to identify its targets, and in particular, the genes recognized by MeCP2 and associated to several neurological and neuropsychiatric disorders. Analysing mechanisms and pathways modulated by these genes, we find that they are involved in three main processes: neuronal transmission, immuno-reactivity, and development. Also, while the nervous system is the most relevant in the pathophysiology of the disorders, additional systems may contribute to MeCP2 action through its target genes. We tested our results with transcriptome analysis on Mecp2-null models and cells derived from a patient with RTT, confirming that the genes identified by our procedure are directly modulated by MeCP2. Thus, MeCP2 may modulate similar mechanisms in different pathologies, suggesting that treatments for one condition may be effective for related disorders.Snow BachNiamh M. RyanPaolo GuasoniAiden P. CorvinRania A. El-NemrDanyal KhanAlbert SanfeliuDaniela TropeaNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 10, Iss 1, Pp 1-13 (2020)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Snow Bach
Niamh M. Ryan
Paolo Guasoni
Aiden P. Corvin
Rania A. El-Nemr
Danyal Khan
Albert Sanfeliu
Daniela Tropea
Methyl-CpG-binding protein 2 mediates overlapping mechanisms across brain disorders
description Abstract MECP2 and its product, Methyl-CpG binding protein 2 (MeCP2), are mostly known for their association to Rett Syndrome (RTT), a rare neurodevelopmental disorder. Additional evidence suggests that MECP2 may underlie other neuropsychiatric and neurological conditions, and perhaps modulate common presentations and pathophysiology across disorders. To clarify the mechanisms of these interactions, we develop a method that uses the binding properties of MeCP2 to identify its targets, and in particular, the genes recognized by MeCP2 and associated to several neurological and neuropsychiatric disorders. Analysing mechanisms and pathways modulated by these genes, we find that they are involved in three main processes: neuronal transmission, immuno-reactivity, and development. Also, while the nervous system is the most relevant in the pathophysiology of the disorders, additional systems may contribute to MeCP2 action through its target genes. We tested our results with transcriptome analysis on Mecp2-null models and cells derived from a patient with RTT, confirming that the genes identified by our procedure are directly modulated by MeCP2. Thus, MeCP2 may modulate similar mechanisms in different pathologies, suggesting that treatments for one condition may be effective for related disorders.
format article
author Snow Bach
Niamh M. Ryan
Paolo Guasoni
Aiden P. Corvin
Rania A. El-Nemr
Danyal Khan
Albert Sanfeliu
Daniela Tropea
author_facet Snow Bach
Niamh M. Ryan
Paolo Guasoni
Aiden P. Corvin
Rania A. El-Nemr
Danyal Khan
Albert Sanfeliu
Daniela Tropea
author_sort Snow Bach
title Methyl-CpG-binding protein 2 mediates overlapping mechanisms across brain disorders
title_short Methyl-CpG-binding protein 2 mediates overlapping mechanisms across brain disorders
title_full Methyl-CpG-binding protein 2 mediates overlapping mechanisms across brain disorders
title_fullStr Methyl-CpG-binding protein 2 mediates overlapping mechanisms across brain disorders
title_full_unstemmed Methyl-CpG-binding protein 2 mediates overlapping mechanisms across brain disorders
title_sort methyl-cpg-binding protein 2 mediates overlapping mechanisms across brain disorders
publisher Nature Portfolio
publishDate 2020
url https://doaj.org/article/892f713a12fe47c58b87bf791fac1f20
work_keys_str_mv AT snowbach methylcpgbindingprotein2mediatesoverlappingmechanismsacrossbraindisorders
AT niamhmryan methylcpgbindingprotein2mediatesoverlappingmechanismsacrossbraindisorders
AT paologuasoni methylcpgbindingprotein2mediatesoverlappingmechanismsacrossbraindisorders
AT aidenpcorvin methylcpgbindingprotein2mediatesoverlappingmechanismsacrossbraindisorders
AT raniaaelnemr methylcpgbindingprotein2mediatesoverlappingmechanismsacrossbraindisorders
AT danyalkhan methylcpgbindingprotein2mediatesoverlappingmechanismsacrossbraindisorders
AT albertsanfeliu methylcpgbindingprotein2mediatesoverlappingmechanismsacrossbraindisorders
AT danielatropea methylcpgbindingprotein2mediatesoverlappingmechanismsacrossbraindisorders
_version_ 1718392806286819328